AQW-051 | Interleukin Related interleukin-related.com

Product Name :
AQW-051

Search keywords :
VQW-765

drugId :
null

Target Vo:
Neuronal acetylcholine receptor protein alpha-7 subunit

Target Vo Short Name :
nAChRα7

Moa_Name:
Neuronal acetylcholine receptor protein alpha-7 subunit agonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Novartis Pharma Ag

Active Company_Name :
Vanda Pharmaceuticals

Active Indication_Name:
Performance Anxiety

In Active Indication_Name:
Alzheimer Disease

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Caspase-10 Rabbit mAb Autophagy
Camrelizumab Technical Information
EEA1 Antibody: EEA1 Antibody is a non-conjugated and Mouse origined monoclonal antibody about 162 kDa, targeting to EEA1. It can be used for WB,IHC-P assays with tag free, in the background of Human, Mouse, Rat.

Author: Interleukin Related

Related Posts